WallStreetZenWallStreetZen

NASDAQ: MLTX
Moonlake Immunotherapeutics Stock Ownership - Who owns Moonlake Immunotherapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Moonlake Immunotherapeutics insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthias BodenstedtChief Financial Officer2026-06-182,794$19.60
$54.76kSell
Kristian ReichChief Scientific Officer2026-06-1750,000$19.43
$971.50kSell
Matthias BodenstedtChief Financial Officer2026-06-1715,082$19.68
$296.81kSell
Kristian ReichChief Scientific Officer2026-06-1650,000$18.70
$935.00kSell
Kristian ReichChief Scientific Officer2026-06-1550,000$18.89
$944.50kSell
Matthias BodenstedtChief Financial Officer2026-05-1113,653$20.02
$273.33kSell
Matthias BodenstedtChief Financial Officer2026-04-142,426$19.56
$47.45kSell
Da Silva Jorge SantosChief Executive Officer2026-04-1351,873$18.23
$945.64kSell
Matthias BodenstedtChief Financial Officer2026-04-101,925$19.51
$37.56kSell
Da Silva Jorge SantosChief Executive Officer2026-04-1098,127$18.41
$1.81MSell

1 of 3

MLTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MLTX insiders and whales buy or sell their stock.

MLTX Shareholders

What type of owners hold Moonlake Immunotherapeutics stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Inc21.74%16,001,284$307.38MInstitution
Deep Track Capital LP8.71%6,408,863$123.11MInstitution
Bihua Chen6.58%4,844,173$93.06MInsider
Cormorant Asset Management LP6.09%4,480,433$86.07MInstitution
Janus Henderson Group PLC4.69%3,451,628$66.31MInstitution
Helix Holdings LLC4.37%3,215,000$61.76MInsider
Da Silva Jorge Santos3.97%2,924,893$56.19MInsider
Kristian Reich3.88%2,859,940$54.94MInsider
D E Shaw Co Inc3.25%2,390,661$45.92MInstitution
Mpm Bioimpact LLC2.46%1,811,082$34.79MInstitution

1 of 3

MLTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MLTX79.56%20.44%Net SellingNet Selling
MAZE88.49%11.51%Net SellingNet Selling
AVLN0.00%29.18%Net BuyingNet Buying
FTRE99.13%0.87%Net SellingNet Selling
GHRS76.01%23.99%
View Top Biotech Stocks

Moonlake Immunotherapeutics Stock Ownership FAQ

Who owns Moonlake Immunotherapeutics?

Moonlake Immunotherapeutics (NASDAQ: MLTX) is owned by 85.71% institutional shareholders, 22.02% Moonlake Immunotherapeutics insiders, and 0.00% retail investors. Bihua Chen is the largest individual Moonlake Immunotherapeutics shareholder, owning 4.84M shares representing 6.58% of the company. Bihua Chen's Moonlake Immunotherapeutics shares are currently valued at $93.06M.

If you're new to stock investing, here's how to buy Moonlake Immunotherapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.